Today: 13 April 2026
Subscribe
Browse Category

Stock Market 5 December 2025

Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Applied Digital (APLD) Stock on December 5, 2025: AI Factory Boom, $16 Billion+ Leases and a New Debt Rating

Fitch assigned a ‘BB-’ rating to senior secured notes issued by an Applied Digital subsidiary, citing both growth and credit risk. Applied Digital shares traded around $30.56 on December 5, up over 200% year-to-date, with market cap near $9 billion and a beta close to 7. The company holds $16 billion in long-term AI data-center contracts.
5 December 2025
···
Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion (BMEA) Stock Jumps on Durable Diabetes Drug Data: Outlook, Analyst Targets and Key Risks as of December 5, 2025

Biomea Fusion shares rose over 10% Friday after the company reported 52-week Phase II data showing its experimental diabetes drug icovamenib sustained HbA1c reductions months after treatment ended. The results, presented at WCIRDC in Los Angeles, included no serious treatment-related adverse events. Despite the gain, Biomea’s stock remains down about 80% over the past year.
5 December 2025
··
Sandisk (SNDK) Stock on December 5, 2025: AI Flash Star, S&P 500 Debut and a New Wave of Analyst Targets

Sandisk (SNDK) Stock on December 5, 2025: AI Flash Star, S&P 500 Debut and a New Wave of Analyst Targets

Sandisk shares closed at $216.66 on December 5, up 1.6%, after surging nearly 500% year-to-date following its February spinoff from Western Digital. The company joined the S&P 500 in late November. China Renaissance initiated coverage with a Buy rating and a $322 price target the same day. Market capitalization stands just over $31 billion.
5 December 2025
···
UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth Group (UNH) Stock on December 5, 2025: Recovery Rally, 2026 Forecasts and the Legal Risks Investors Can’t Ignore

UnitedHealth shares traded at $332–$334 on December 5, 2025, rebounding from May lows in the $230s after a year marked by a DOJ probe and a major data breach. The stock remains about 45% below its December 2024 high near $610. Analysts estimate 2025 EPS at $16.29, down 41% from the prior year. Simply Wall St values UNH at $847 per share, suggesting a 60% discount to intrinsic value.
5 December 2025
··
Robinhood (HOOD) Stock Today: Prediction Markets Push, Crypto Volatility and Wall Street Targets – December 5, 2025 Update

Robinhood (HOOD) Stock Today: Prediction Markets Push, Crypto Volatility and Wall Street Targets – December 5, 2025 Update

Robinhood shares traded near $133 midday December 5, down 3%, with a market cap of about $120 billion. The stock remains up over 200% in 2025, despite recent volatility. Needham reiterated a Buy rating and $145 target, following several analyst target hikes in November. Recent 13F filings show institutions including M&T Bank and Schroders increasing stakes.
5 December 2025
·
Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. (AGX) Stock Plunges After Record-Backlog Q3: What Today’s Selloff Means for Investors

Argan, Inc. shares plunged about 15% to $302 in Friday morning trading after Q3 fiscal 2026 results showed an EPS beat but missed revenue estimates. The company reported record backlog near $3.0 billion and improved margins, but analysts downgraded the stock and insiders sold over $29 million in shares in the past 90 days. Argan holds no debt and $727 million in cash.
5 December 2025
·
Walmart (WMT) Stock Near Record High Ahead of Nasdaq Move and CEO Change – All the Latest News and 2026 Forecasts

Walmart (WMT) Stock Near Record High Ahead of Nasdaq Move and CEO Change – All the Latest News and 2026 Forecasts

Walmart shares traded near $115.66 Friday afternoon, approaching record highs after strong Q3 FY26 earnings and raised 2026 guidance. The stock is up 27% year to date, giving the company a market value above $900 billion. Revenue for the quarter reached $179.5 billion, up 5.8% from a year ago. Walmart will soon move to the Nasdaq and undergo a CEO transition.
5 December 2025
·
Bank of Canada Rate Cuts Are Likely Over: What a 2.25% Policy Rate Means for Mortgages, Housing and TSX Mid‑Cap Stocks

Bank of Canada Rate Cuts Are Likely Over: What a 2.25% Policy Rate Means for Mortgages, Housing and TSX Mid‑Cap Stocks

The Bank of Canada is expected to hold its policy rate at 2.25% on December 10, after 275 basis points of cuts since the start of its easing cycle. A Reuters poll of 33 economists shows no further cuts are likely until at least 2027. Unemployment fell to 6.5% in November, the lowest in 16 months. Variable mortgage rates are seen staying steady as affordability improves from 2022–23 peaks.
5 December 2025
···
AppLovin (APP) Stock on 5 December 2025: AI Rocket, SEC Clouds and What Wall Street Expects Next

AppLovin (APP) Stock on 5 December 2025: AI Rocket, SEC Clouds and What Wall Street Expects Next

AppLovin shares closed at $690.12 on December 5, up nearly 1% and capping a 1,749% two-year gain—the strongest among large-cap U.S. stocks. The company reported Q3 revenue of $1.405 billion and net income of $836 million, both up sharply year over year. AppLovin faces an SEC probe into data practices and heavy insider selling. Market cap stands above $230 billion.
5 December 2025
··
Eli Lilly (LLY) Stock Outlook: Can the Obesity-Drug Giant Keep Justifying a $1,000 Share Price?

Eli Lilly (LLY) Stock Outlook: Can the Obesity-Drug Giant Keep Justifying a $1,000 Share Price?

Eli Lilly shares traded above $1,000 on December 5, 2025, after recently crossing a $1 trillion market cap, the first for a healthcare company. The stock is up over 30% year to date despite an 8% pullback in the past week. Lilly is cutting prices on its obesity drug Zepbound and preparing to seek accelerated approval for a new weight-loss pill. The company’s dividend yield remains around 0.6%.
5 December 2025
··
Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast Stock (CMCSA) Rises as Versant Spin-Off Nears: Latest News, Analyst Targets, and 2026 Outlook

Comcast shares traded at $27.81 midday Friday, up 2.2%, after the board approved the Versant Media Group spin-off. The stock remains well below its 52-week high of $43.30 and is down 13% over the past year, underperforming the S&P 500. Comcast shareholders will receive one Versant share for every 25 Comcast shares held, with the spin-off distribution set for January 2, 2026.
5 December 2025
··
Intel Stock Today: Apple Foundry Rumors, $208M Malaysia Bet and a U‑Turn on NEX – What It All Means for INTC Investors (5 December 2025)

Intel Stock Today: Apple Foundry Rumors, $208M Malaysia Bet and a U‑Turn on NEX – What It All Means for INTC Investors (5 December 2025)

Intel shares rebounded to around $42–43 on December 5 after a 7.4% drop the previous day. The stock is up about 100% in 2025, fueled by government and strategic investments, a $208 million Malaysia expansion, and speculation about Apple as a customer. Wall Street remains cautious, with consensus price targets below current levels and several analysts rating the stock “Reduce.”
5 December 2025
·
Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle (ORCL) Stock Today: AI Cloud Backlog, Debt Warnings and What to Expect from Dec. 10 Earnings

Oracle shares rose to about $217 in late morning trading December 5, up 3% from Wednesday’s close and valuing the company near $610 billion. The move follows renewed optimism over Oracle’s AI-driven cloud strategy ahead of fiscal Q2 earnings on December 10. Analysts expect revenue growth of around 15% and adjusted EPS of $1.64. Oracle’s debt-to-equity stands at roughly 3.3×, with a current ratio near 0.62.
5 December 2025
·····
MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials Stock (NYSE: MP): Morgan Stanley Upgrade, Saudi JV and a 41% Pullback – December 5, 2025 Update

MP Materials shares traded at $62.90 on December 5, up 1.8% after Morgan Stanley upgraded the stock to Overweight with a $71 target. The stock is down 41% from its 2025 peak near $100 but remains up over 270% year-to-date. Analyst targets mostly cluster between $70 and $80, though some models suggest fair value is closer to $46. Trading volume surged following renewed analyst optimism.
5 December 2025
·
Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics (SNSE) Stock: Wild Volatility After Solnerstotug Shutdown and Strategic Review – Price, News and 2025–2026 Forecast

Sensei Biotherapeutics shares closed at $10.56 on December 4, 2025, up 21%, then surged to $17.20 after hours, nearing a 52-week high. The spike came despite no new company news and follows the recent shutdown of its lead drug program and a strategic review. Market cap hovered around $10–11 million. Major shareholder Cambrian BioPharma filed to sell 21,222 shares the same day.
5 December 2025
··
1 … 1,067 1,068 1,069 1,070 1,071 … 1,375

Stock Market Today

  • FinVolution Group Insider Stock Option Purchase Sparks Debate on Valuation and Growth
    April 12, 2026, 8:59 PM EDT. FinVolution Group (FINV) saw insider Tiezheng Li buy a large block of stock options, signaling confidence amid a subdued market showing a 5.53% decline in the past 30 days and a 33.21% drop over one year. Despite mixed signals, FinVolution's fair value estimate stands at $7.61 versus a last close of $4.95, suggesting potential undervaluation. The company's institutional funding and convertible bonds support international growth and shareholder returns, but concerns loom over tighter Chinese consumer finance regulations and rising delinquency rates. Investors face a complex balance between growth prospects and regulatory risks.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Go toTop